Skip to main content

Table 4 Laboratory findings of adult COVID-19 patients with different levels of HDL-C

From: Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study

  Normal range Low HDL (n = 46) High HDL (n = 182) P value
White blood cell count, ×109/L, median (IQR) 4–10 4.78 (3.82, 6.13) 4.58 (3.52, 5.66) 0.627
Lymphocyte count, ×109/L, median (IQR) 0.8–4.0 1.02 (0.72, 1.51) 1.17 (0.84, 1.59) 0.207
Lymphocyte %, median (IQR) 20–40 22.35 (17.58, 30.10) 27.45 (20.05, 33.00) 0.050
Alanine aminotransferase, U/L, median (IQR) 0–42 21.49 (16.13, 30.28) 18.81 (13.81, 26.61) 0.044
Aspartate aminotransferase, U/L, median (IQR) 0–37 25.87 (19.53, 34.01) 23.76 (19.25, 28.77) 0.109
Total bilirubin, μmol/L, median (IQR) 3.4–20.5 11.16 (8.16, 15.35) 10.87 (8.68, 16.36) 0.769
C-reactive protein, mg/L, median (IQR) 0–8 27.83 (14.68, 44.74) 12.56 (3.29, 26.88) < 0.001
Erythrocyte sedimentation rate, mm/h, median (IQR) 0–15 52.00 (22.00, 67.75) 39.50 (22.0, 68.25) 0.538
Procalcitonin, ≥0.05 ng/mL, No. (%) < 0.05 17 (37.0%) 46 (25.3%) 0.113
Creatinine, μmol/L, median (IQR) 21.5–104 53.70 (43.61, 65.02) 50.85 (41.22, 64.02) 0.209
Creatine kinase, U/L, median (IQR) 10–190 83.35 (57.05, 148.63) 69.75 (46.30, 114.45) 0.116
Creatine kinase-MB, U/L, median (IQR) 0–24 9.35 (5.33, 12.50) 9.57 (6.40, 12.92) 0.624
  1. P < 0.05 was considered statistically significant (marked in bold)
  2. COVID-19 Coronavirus disease 2019; HDL-C High density lipoprotein cholesterol; IQR Inter-quartile range